OPCH
Option Care Health, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$24.21
−1.02%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.7B | 5.6B | 5.0B | 4.3B | 3.9B |
| Cost of Revenue | 4.7B | 4.6B | 4.0B | 3.3B | 3.1B |
| Gross Profit | 1.0B | 1.0B | 1.0B | 981.2M | 866.9M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 675.3M | 682.5M | 630.3M | 607.4M | 566.1M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 21.0M | — | 60.9M | 59.2M | 60.6M |
| Total Operating Expenses | 696.3M | 682.5M | 691.2M | 666.6M | 626.7M |
| Cost and Expenses | 5.4B | 5.3B | 4.7B | 4.0B | 3.7B |
| Operating Income (EBIT) | 338.3M | 337.9M | 321.8M | 314.6M | 240.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 58.4M | 63.2M | 60.6M | 62.2M | 54.9M |
| Net Interest Income | (58.4M) | (63.2M) | (60.6M) | (62.2M) | (54.9M) |
| Other Non-Op Income/Expense | (52.8M) | (55.0M) | (38.2M) | 44.1M | (34.5M) |
| Non-Operating Income (excl Interest) | (5.6M) | (8.2M) | (10.8M) | (95.4M) | (19.3M) |
| EBT (Pre-Tax Income) | 285.5M | 282.9M | 283.6M | 358.7M | 205.8M |
| Income Tax Expense | 75.9M | 75.3M | 71.8M | 91.7M | 55.2M |
| Bottom Line | |||||
| Net Income | 209.6M | 207.6M | 211.8M | 267.1M | 150.6M |
| Earnings from Cont. Ops | 209.6M | 207.6M | 211.8M | 267.1M | 150.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 209.6M | 207.6M | 211.8M | 267.1M | 150.6M |
| Per Share | |||||
| Basic EPS | $1.33 | $1.28 | $1.23 | $1.49 | $0.83 |
| Diluted EPS | $1.33 | $1.27 | $1.23 | $1.48 | $0.83 |
| Revenue Per Share | $36.78 | $34.85 | $29.13 | $24.04 | $21.78 |
| Shares | |||||
| Basic Shares Outstanding | 154.8M | 162.1M | 171.6M | 179.0M | 181.1M |
| Diluted Shares Outstanding | 155.8M | 163.4M | 172.8M | 180.4M | 182.1M |
| Profitability Metrics | |||||
| EBITDA | 415.3M | 416.8M | 396.1M | 472.2M | 325.0M |
| D&A | 71.4M | 70.7M | 63.5M | 62.2M | 65.4M |
| EBIT | 343.9M | 346.1M | 332.6M | 410.0M | 259.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026